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Abstract
Background: Emerging evidence of histopathological analyses suggests that endothelial progenitor cells (EPCs) play an
important role in vascular diseases. Neointimal hyperplasia can be reduced by intravenous transfusion of EPCs after vascular
injury in mice. Therefore, it would be advantageous to develop an in vivo technique that can explore the temporal and
spatial migration of EPCs homing to the damaged endothelium noninvasively.
Methodology/Principal Findings: The left carotid common artery (LCCA) was injured by removal of endothelium with a
flexible wire in Kunming mice. EPCs were collected by in vitro culture of spleen-derived mouse mononuclear cells (MNCs).
EPCs labeling was carried out in vitro using Fe2O3-poly-L-lysine (Fe2O3-PLL). In vivo serial MR imaging was performed to
follow-up the injured artery at different time points after intravenous transfusion of EPCs. Vessel wall areas of injured artery
were computed on T2WI. Larger MR signal voids of vessel wall on T2WI was revealed in all 6 mice of the labeled EPC
transfusion group 15 days after LCCA injury, and it was found only in 1 mouse in the unlabeled EPC transfusion group
(p=0.015). Quantitative analyses of vessel wall areas on T2WI showed that the vessel wall areas of labeled EPC transfusion
group were less than those of unlabeled EPC transfusion group and control group fifteen days after artery injury (p,0.05).
Histopathological analyses confirmed accumulation and distribution of transfused EPCs at the injury site of LCCA.
Conclusions/Significance: These data indicate that MR imaging might be used as an in vivo method for the tracking of EPCs
homing to the endothelium injured artery.
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Introduction
Percutaneous transluminal angioplasty (PTA) and stenting are
increasingly being used for the treatment of atherosclerotic
stenosis. However, neointimal hyperplasia, restenosis and late
stent thrombosis remain a source of frustration [1–3]. Endothelial
dysfunction is considered to be the initiation of arteriosclerosis
process, and endothelial damage is a major cause of neointimal
hyperplasia and restenosis after endoluminal procedure [4,5].
Recently, emerging evidence suggests that endothelial progenitor
cells (EPCs) play an important role in the prevention of
arteriosclerosis, reduction of neointima formation and attenuation
of restenosis by promoting re-endothelialization [6–8].
By histopathological analyses, intravenous transfusion of EPCs
homing to the site of vascular injury and resulting in an enhanced
re-endothelialization associated with decreased neointima forma-
tion was demonstrated [7]. The ability to inhibit neointimal
hyperplasia can be further enhanced by genetically engineered
EPCs [9]. However, it would be advantageous to develop an in
vivo technique that can monitor the transplanted cells. Especially
it might be extremely useful for the potential clinical application in
the future.
Several studies have confirmed the applicability of in vivo MR
imaging in the observation of artery injury and arteriosclerosis in
different animal models [10–12]. With superparamagnetic iron
oxide (SPIO)-based method, some researchers have initially
investigated the feasibility of MR techniques for in vivo cellular
imaging in animal models of different diseases [13–17]. A study by
Shapiro et al showed that in vivo MR can even detect a single
group of cells homing to tissue following cell labeling and
transplantation [18]. We postulate that in vivo MR imaging may
be a potential new technique to explore the temporal and spatial
migration of EPCs homing to the damaged endothelium
noninvasively.
Results
Animal Model and EPCs
Splenectomy and carotid artery injury were successfully
performed in all of the mice.
In vitro cultured spleen-derived MNCs showed the typical
‘‘cobblestone’’ appearance of endothelial cells (Figure 1A). The
cells showed expression of CD31, CD34 and vWF with the
cytoplasm stained in brown, confirming that the cells had typical
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(Figure 2). Cultured EPCs that had taken up DiI-ac-LDL
displayed red fluorescent aggregates (Figure 3B). Cultured EPCs
bound to the endothelial cell specific FITC-UEA I were green
fluorescent aggregates (Figure 3C). EPCs that had taken both DiI-
ac-LDL and FITC-UEA I displayed yellow fluorescence in the
cytoplasm (Figure 3D). Blue particles could be seen in almost every
Fe2O3-PLL labeled cell in Prussian blue staining (Figure 1B).
In Vivo MR Imaging
The signal voids of lumen, wall thickening of injured artery and
exudation around injured artery were clearly observed on serial
PDWI in company with T1WI and T2WI at different time points
(Figure 4). Before artery injury, LCCA (left carotid common
artery) looked normal (as ring) on MR image without wall
thickening and stenosis. One day after artery injury, deformation
of LCCA was obvious on all sequences of MR image. Evident
exudation due to inflammatory reaction around LCCA was
observed on T2WI within 10 days after artery injury. RCCA (right
carotid common artery) looked normal at MR image, without wall
thickening and stenosis.
Larger MR signal voids of vessel wall on T2WI was revealed in
all 6 mice in the labeled EPC transfusion group at 15 days after
LCCA injury (Figure 4P, 4Q), while it was found only in 1 mouse
in the unlabeled EPC transfusion group (p=0.015), which
indicated that the SPIO particles may be contributed to the large
MR signal voids of vessel wall due to their properties of T2WI
sensitivities.
Vessel wall areas of LCCA were quantitatively analyzed on
T2WI at different time points (Figure 5). There were significant
differences of vessel wall area among the three groups 10 day
(x
2=6.678, p=0.035) and 15 days (x
2=12.433, p=0.002) after
artery injury. The vessel wall area of labeled EPC transfusion
group were less than that of unlabeled EPC transfusion group and
control group at 15 days after arterial injury (0.28960.065 mm
2
vs. 0.57860.187 mm
2,u=2.000, p=0.010; 0.28960.065 mm
2 vs.
0.85560.202 mm
2, u=0.000, p=0.004). Also, there was a
significant difference of vessel wall areas between unlabeled EPC
transfusion group and control group 15 days after artery injury
(0.57860.187 mm
2 vs. 0.85560.202 mm
2, u=5.000, p=0.037).
Histopathological Findings
Laser scanning confocal microscopic analysis (Figure 6A, 6C)
and H&E staining (Figure 6B, 6D) demonstrated accumulation of
transfused Dil-Ac-LDL-labeled EPCs at the injury site after
endothelium damage of LCCA. Prussian blue staining confirmed
blue particles of Fe2O3-PLL labeled EPCs distributing in the
injured endothelium (Figure 7A,7B). Intimal hyperplasia of LCCA
was visible in all the animals of the three groups, and crescentic
neointima of LCCA was confirmed in two animals of control
group (Figure 7C). No intimal hyperplasia of right common
carotid artery (RCCA) was found.
Discussion
EPC was isolated primarily in 1997 by Asahara et al [19], and
has been extensively studied in cardiovascular diseases [20,21].
MR imaging holds several advantages for tracking cells in vivo,
Figure 1. spleen-derived EPCs. EPCs showed endothelium-like
cobblestone morphology with characteristic formation of clusters (A).
Blue particles are clearly visible in almost every labeled cell with
Prussian blue staining (B). (Magnification 6200).
doi:10.1371/journal.pone.0020790.g001
Figure 2. Immunostaining of spleen-derived EPCs. 7 days after in
vitro differentiation, spleen-derived EPCs showed expression of CD31
(B), CD34 (C) and vWF (D) with the cytoplasm stained in brown. Photo A
is the control. Hematoxylin-stained nuclei were shown in blue.
(Magnification 6400).
doi:10.1371/journal.pone.0020790.g002
Figure 3. Endothelial cell characteristics. After 7 days culture (A),
cells taken up DiI-ac-LDL were red fluorescence (B), bound to FITC-UEA-I
displayed green fluorescence (C), and the double-stained cells showed
yellow fluorescence in cytoplasm (D). (Magnification 6200).
doi:10.1371/journal.pone.0020790.g003
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penetration depth, etc. In vivo MR imaging therefore appears
promising for dynamically monitoring cell migration after
transplantation. For the tracking of EPCs using MR imaging, in
vitro labeling of the cells is essential. As a MR imaging contrast
agent, SPIO which creates hypointense signals on T2WI has been
widely used in cell labeling [22–24]. The administration of
ferumoxides-poly-L-lysine labeled human stem cells appeared not
to have a significant effect on hematology, blood chemistry
indicators, or organ function in rats [25]. It was found that the iron
in endosome was not released into the cytoplasm as a free radical
form, which would be toxic to the cells [26]. After many iron
particles were injected into single-cell embryos, the embryos
developed normally, which indicates that the iron particles may be
nontoxical to embryos development [27]. Both peripheral blood
derived EPCs and spleen derived EPCs can be effectively labeled
using Fe2O3-PLL with little influence on cells’ biological properties
[23,28]. The spleen derived EPCs labeled with Fe2O3-PLL can
even be detected as a single group of cells on in vitro MR imaging
using high field strength 7T MR scanner [28]. Based on these
studies, we used Fe2O3-PLL to label spleen derived EPCs in vitro
for MR imaging in the current study.
The imaging artifact caused by iron oxide particles may be
several times larger than the labeled cell [29]. As transfused EPCs
might attach to the injured endothelium and contribute to the re-
endothelialization, transfusion of Fe2O3-PLL labeled EPCs led to
large signal voids of vessel wall on T2WI presumably due to SPIO
induced signal intense loss in the present study (Figure 4, 5). The
accumulation of transfused Dil-Ac-LDL-labeled EPCs at the site
of injured endothelium confirmed by Laser scanning confocal
microscopic observation and histopathological analysis validated
spleen-derived EPCs transfused intravenously homing to the
injured artery (Figure 6). The blue particles of Fe2O3-PLL labeled
EPCs distributing in the injured endothelium demonstrated by
Prussian blue staining showed that the SPIO are efficiently labeled
with EPCs as the protocol (Figure 7). Our study shows
encouraging results that in vivo cellular MR imaging may be a
potential method for the tracking of EPCs transfused intravenous-
Figure 4. In vivo serial MR imaging. Figure 4A–4E, Figure 4G–4K and Figure 4M–4Q indicated T2WI. Figure 4F, 4L, and 4R indicated PDWI. Before
artery injury, LCCA appeared normal on MR image without wall thickening and stenosis. After artery injury, wall thickening and stenosis of LCCA was
obviously observed. Large MR signal voids of vessel wall was revealed on T2WI at 10 days and 15 days after artery injury (Arrow, Figure 4P, 4Q).
However, the vessel wall was visible on PDWI (arrow head, Figure 4R).
doi:10.1371/journal.pone.0020790.g004
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2) of LCCA measured on T2WI at different time points. There was no significant difference of vessel wall area
among the three groups 1 day and 5 days after artery injury. However, vessel wall area of labeled EPC transfusion group was significantly less than
that of unlabeled EPC transfusion group and control group at 15 days after artery injury. Vessel wall areas of EPCs transfusion group were significantly
less than that of non-EPC transfusion group at 15 days after artery injury.
doi:10.1371/journal.pone.0020790.g005
Figure 6. Transfused EPCs contribute to reendothelialization. Laser scanning confocal microscopic analysis (6A, 6C) and H&E staining (6B, 6D)
demonstrated accumulation of transfused Dil-Ac-LDL-labeled EPCs at the injury site 5 days (6A, 6B) and 10 days (6C, 6D) after endothelium damage of
LCCA. (Magnification 6200).
doi:10.1371/journal.pone.0020790.g006
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in 1 mouse in the unlabeled EPC transfusion group at 15 days
after LCCA injury. We presume that a potential reason for this to
happen was mismatching of MR imagings at different time points.
It was reported that endosomal iron nanoparticles could be
detected after seven weeks in nondividing human mesenchymal
stem cells, and intracellular iron had disappeared by five to eight
divisions in rapidly dividing cells [30]. In the study by Shapiro et
al, a single group of particles injected into single cell-stage mouse
embryos could be detected at embryonic day 11.5, demonstrating
that daughter cells carry a single group of particles can still be
detected even after many cell divisions [27]. The strength of the
present study is that individual carotid artery was followed serially
by in vivo MR imaging of T2WI after EPC transfusion. In vivo
quantitative analysis on MR imaging is also a strength feature in
this study. The approach provides in vivo insights into the natural
history of SPIO-labeled EPCs in endothelial injury. The data
indicated that vessel wall area on T2WI in SPIO-labeled EPC
transfusion group was less than those in unlabeled EPC transfusion
group and control group at fifteen days after artery injury. Vessel
wall area measured on T2WI not only accounts for signal intense
loss induced by SPIO but also indicates neointimal hyperplasia
indirectly. The vessel wall area of unlabeled EPC transfusion
group was not as much as that of control group fifteen days after
artery injury in the present experiment (Figure 5). The result was
similar to previous studies which suggested that EPCs may
contribute to endothelial regeneration thereby limiting neointimal
hyperplasia [7,31]. Our quantitative data on MR imaging
accurately showed the homing of EPCs and their role on the
repair of artery injury.
To what extents the transfused EPCs die and release SPIO
particles may pose a problem. It was considered that any SPIO
released into the blood would be taken up by the Kupffer cells in
the liver and in the reticuloendothelial system in the spleen
[32,33]. Although spleen was dissected to prolong the circulating
time of EPCs in the peripheral circulation and allow homing of
transfused spleen-derived EPCs to the injured artery rather than to
the spleen, we did find SPIO in the liver of mice in the current
study (data not presented). Therefore, it is unlikely that the iron
particles released from labeled EPCs would be a problem in
the observation of endothelium injury in carotid artery. The
correlationship between MR imaging and histopathology has been
demonstrated by several studies on neointimal hyperplasia and
atherosclerotic plaque in different animal models [10–12],
however, we can not answer the correlationship between the
numbers of Fe2O3-PLL labeled EPCs transfused intravenously and
signal intense loss of vessel wall based on the limited data, which is
one of the major limitations of the current study.
In conclusion, initial evidence from our study implies that in
vivo MR imaging can noninvasively and dynamically depict
systemically administered EPCs homing to injured endothelium on
the basis of cell labeling with SPIO in mice. Moreover, in vivo
quantitative analysis for signal intense loss of vessel wall on T2WI
induced by SPIO labeled EPCs is feasible on MR imaging. We
believe that such an experimental platform of in vivo cellular MR
imaging would open the door to understand treatment efficacy of
transplanted cells in arterial diseases.
Materials and Methods
Animal Model
All animal procedures were carried out in accordance with
approvals and the guidelines of Institutional Animal Care and Use
Committee (IACUC) of Medical School of Southeast Universi-
ty(approval ID: SYXK-2007.2122). A total of 22 male Kunming
mice (Animal Center of Southeast University, Nanjing, China),
18–20 weeks of age weighted at 35.0–45.0 g, were recruited, and
fed with conventional diet.
Animal model was established based on modifications of
previously described methods [34,31]. Animals were anesthetized
by intraperitoneal injection of 80 mg/kg Pentobarbital (Shanghai
Chemical Reagent Co., Shanghai, China). The spleen was
dissected through a lateral incision of the left abdomen. Carotid
artery injury was carried out seven days after spleenectomy. The
bifurcation of the left common carotid artery (LCCA) was exposed
under a dissecting microscope (ZOOM645S, Jiangnan Yucheng,
Figure 7. Histopathological analysis. Prussian blue staining showed blue particles of Fe2O3-PLL labeled EPCs distributing in subendothelium
(Figure 7A, 7B indicated 5, 10 days after endothelium injury respectively). Figure 7C showed crescentic neointima of injured artery in 2 animals of non-
EPC transfusion group. (Magnification 6200).
doi:10.1371/journal.pone.0020790.g007
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the external carotid artery. The distal ligature was then tied off.
After temporary occlusion of the internal and common carotid
artery, an incision hole was made between the ligatures of the
external carotid artery. A curved flexible wire with 0.27 mm in
diameter was introduced into the LCCA via the incision. The wire
was passed along the LCCA in a rotating manner for three times.
After removal of the wire, the proximal ligature of the external
carotid artery was tied off. Normal blood flow was reassured, and
the skin was closed with single sutures using 6/0 silk.
Spleen-Derived EPCs and Their Characteristics
Based on modifications of previously described methods [7,31],
spleens from Kuming mice (Animal Center of Southeast
University, Nanjing, China) were explanted and mechanically
minced. The cells suspended in 6 ml PBS were centrifuged in a
density-gradient centrifuge Histo-Paque 1077 (Sigma-Aldrich, St.
Louis, MO) at 400 g for 30 min. A sediment layer of mononuclear
cells (MNCs) was collected, washed twice with PBS, suspended in
microvascular growth medium-2 (EGM-2; Cambrex, Walkersville,
MD) and adjusted to a concentration of 2610
6/ml. The mononu-
clear cells were placed in 6-well or 24-well culture plate (Corning
Inc., Corning, NY) and cultured at 37uC under 100% humidity
and 5% CO2. 3 days after, the suspended cells were removed and
the cells adhering to the plate wall were fed every 3 days with fresh
culture medium.
After 7 days in culture, spleen-derived EPCs in 4 wells of a 24-
well culture plate were extensively washed, and fixed in ice-cold
4% paraformaldehyde for 20 min. Immunocytochemistry was
performed using antibodies against CD31, CD34 (Wuhan Boster
Biological Technology, LTD. Wuhan, China) and von Willebrand
factor (vWF) ( Zhongshan Goldenbridge Biotechnology Co., LTD.
Beijing, China) according to standard protocols.
Spleen-derived EPCs that had been cultured for 7 days were
incubated in one well of a 6-well culture plate with 2.0 mL culture
medium containing 10 mg/ml DiI-Ac-LDL (1, 19-dioctadecyl-3, 3,
39,3 9- tertamethylindo-carbocyanine -labeled acetylated low-
density lipoprotein) (Biomedical Technologies Inc., Stoughton,
MA) at 37uC for 6 hours. Then the cells were washed with PBS
twice and fixed in 4% paraformaldehyde for 20 min. The fixed
cells were then incubated with 1 mL (10 mg/ml) FITC-UEA I
(Vector Laboratories Inc., Burlingame, CA) at 37uC for 1 hour.
EPCs were observed under a laser scanning confocal microscope
(LSM 510; Zeiss Co. Ltd., Oberkochen, Germany). The adherent
cells that stained positive with both FITC-UEA I and DiI-Ac-LDL
were indicated to be differentiating endothelial cells.
Cell Labeling
The preparation of superparamagnetic particles Fe2O3-poly-L-
lysine (Fe2O3-PLL) and cell labeling were carried out based on
previously described methods [22]. Spleen-derived EPCs that had
been cultured for 4–6 days were incubated in one well of a 6-well
culture plate with 2.0 mL culture medium containing 20 mg/ml
Fe2O3-PLL for 12 hours. After incubation, the EPCs were washed
with phosphate-buffered saline 3 times to remove excess Fe2O3-
PLL. For Prussian blue staining, the cells were incubated with 2%
potassium ferrocyanide (Shantou Xilong Chemical Inc., Guang-
dong, China) in 6% hydrochloric acid (HCl) and then counter-
stained with nuclear fast red, which reveals the cells’ profile and
intracellular iron particles.
Animal Groups and Cell Transfusion
After 5–7 days in culture, cell transfusion was carried out by
intravenous tail vein injection directly after induction of arterial
injury and again 24 hours later. The mice (n=22) were randomly
divided into four groups. In group one, the mice received 1610
6/
0.5 ml Fe2O3-PLL labeled EPCs (labeled EPC transfusion group,
n=6). In group two, the mice received 1610
6/0.5 ml unlabeled
EPCs (unlabeled EPC transfusion group, n=6). In group three,
the mice received a corresponding amount of phosphate buffered
solution (PBS) (control group, n=6). In group four, two mice
received 1610
6/0.5 ml Fe2O3-PLL labeled EPCs, and two mice
received 1610
6/0.5 ml DiI-Ac-LDL labeled EPCs. The mice were
observed with in vivo serial MR imaging and sacrificed after the
last MR imaging in group one, group two and group three (n=18,
6 mice in each group). The mice of group four were sacrificed at 5
days (n=2) and 10 days (n=2) respectively after artery injury for
histopathological analysis of transplanted DiI-Ac-LDL labeled
EPCs and iron particles in vessel wall of LCCA.
In Vivo MR Imaging
In vivo MR imaging of the injured artery was performed on a
7T Micro-MR imaging system (Bruker PharmaScan micro-MR,
Germany) with a 35-mm birdcage coil at different time points
(before, 1, 5, 10 and 15 days after artery injury).
The mice were positioned in the prone position and a pressure-
sensitive pad for respiratory gating was placed on the abdomen.
The mice were anesthetized with 1.0% to 1.5% isoflurane
(Shandong Keyuan Pharmaceuticals Company, Jinan, China)
with air and oxygen mixed at a 3:1 ratio. We regulated the flow of
isoflurane to maintain the respiratory rate at approximately 60–80
breaths per minute. The respiratory signals were used to
synchronize image acquisition to reduce imaging artifacts due to
respiratory motions.
We acquired T1-, T2-, and proton density-weighted images
(T1WI, T2WI and PDWI, TR/TE 1300.0/7.5, 2535.9/65.0, and
2535.9/13.0 msec, respectively) using rapid acquisition with
relaxation enhancement sequence (T1WI) and multi slice multi
echo sequence (T2WI and PDWI). The slice thickness was
0.6 mm, the field of view was 3.063.0 cm
2, the matrix size was
2566256, and the resolution was 11761176600 mm
3. Two signal
averages were used in T1WI, and one signal average was used in
T2WI and PDWI.
Source images were reconstructed and analyzed using the
scanner console (Paravision; Bruker Biospin, Billerica, MA, USA).
Vessel wall area was computed based on the cross section of image
with the most significant vessel wall thickening and lumen
narrowing. At different time points of MR imaging, the same
section LCCA was analyzed in each mouse. The bifurcation of
common carotid artery was used as a marker to ensure the same
slice of LCCA was analyzed in each mouse at different time points
of MR imaging and histological slides.
Histopathological Analysis
Animals to be sacrificed were anesthetized by intraperitoneal
injection of 80 mg/kg Pentobarbital (Shanghai Chemical Reagent
Co., Shanghai, China). In situ perfusion fixation was achieved with
injecting 4% phosphate-buffered paraformaldehyde into the left
ventricle. The carotid arteries were excised. Perfusion-fixed
carotid arteries were embedded in Tissue Tek OCT embedding
medium (Sakura, Fine technical Co., Ltd., Tokyo, Japan), snap-
frozen, and stored at 280uC. The specimens were sectioned into
slices of 6–10 mm in thickness for laser scanning confocal
microscopic analysis (LSM 510; Zeiss Co. Ltd., Oberkochen,
Germany) to observe DiI-Ac-LDL, for hematoxylin-eosin staining
to display tissue morphology and for Prussian blue staining to
identify iron particles.
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All obtained quantitative data were expressed as means 6
standard deviation (SD). Statistical analyses were performed with
the SPSS software (SPSS for Windows, version 11.0, 2001; SPSS,
Chicago, IL). Test for several independent samples (Kruskal-
Wallis H) was used to test the difference of vessel wall area among
groups. The significances of vessel wall area between two groups
were determined by test for two independent samples (Mann-
Whitney U). Fisher’s exact test was employed to determine the
significance of the cases with large MR signal voids of vessel wall
between two groups. P values,0.05 were considered statistically
significant.
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